What role does Metformin play in reducing or influencing inflammatory markers in systemic conditions and how might this contribute to its broader health benefits?
Gaurav ChauhanContributor
What role does Metformin play in reducing or influencing markers of inflammation in systemic conditions?
Share
Metformin reduces inflammatory markers like CRP and IL-6, potentially lowering chronic inflammation and risk of diseases like type 2 diabetes and cardiovascular disorders.
Metformin reduces inflammation by inhibiting the NF-kB pathway, which may lower risk of chronic diseases like type 2 diabetes and cardiovascular ailments.